Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.135
-0.005 (-0.44%)
At close: Oct 23, 2026, 4:00 PM EDT
1.101
-0.034 (-2.96%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Acurx Pharmaceuticals the 42,151st largest employer in the world and 6,650th in the United States.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,876,555
Market Cap
5.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2024 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Sep 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Mar 31, 2021 | 3 | - | - | 2 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Senti Biosciences Holdings | 39 |
| Moleculin Biotech | 17 |
| Processa Pharmaceuticals | 12 |
| Aprea Therapeutics | 8 |
| Traws Pharma | 7 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
ACXP News
- 3 days ago - Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect - PRNewsWire
- 8 days ago - Acurx Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 25 days ago - Acurx enrolls first patient in clinical trial of Ibezapolstat in rCDI - TheFly
- 25 days ago - Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection - PRNewsWire
- 5 weeks ago - Acurx Announces Presentation of a Scientific Poster at the Premier International C. difficile Symposium (ICDS) Demonstrating Superior In Vitro Kill Kinetics of Ibezapolstat vs. - PRNewsWire
- 6 weeks ago - Acurx Pharmaceuticals Registration statement: Registration filing - Filings
- 7 weeks ago - Acurx Pharmaceuticals Proxy statement: Proxy filing - Filings
- 7 weeks ago - Acurx Pharmaceuticals Proxy statement: Proxy filing - Filings